Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

The Effectiveness of Education in Diabetic Hemodialysis Patients

NCT07462741 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-26
Last updated
2026-03-10

Condition(s) studied

Hemodialysis PatientDiabetes Foot Care

Investigational drug(s) / intervention(s)

Diabetic Foot Care Training

Diabetic Foot Care Training: The training will be conducted using an educational booklet prepared in accordance with the Health Belief Model. After collecting pre-test data, the training will be given to the experimental group for 2 weeks, and in order to ensure behavioral change in 4 weeks, reminders about foot care will be given to patients in dialysis centers or by phone, and then the final test data will be applied to both the experimental and control groups. During this process, the control group will continue to receive standard treatment and no intervention will be performed.

Study summary

Diabetes is a significant health problem affecting approximately half a billion people worldwide, reaching alarming levels. Diabetic foot ulcers are among the most common and serious complications of diabetes. Diabetes is the most common cause of end-stage renal failure, and diabetic nephropathy is identified as a major risk factor for foot ulcers and amputation. The health belief model is a model that explains behavior. Focusing on the necessary motivational resources for the development of positive health behaviors in individuals is crucial for positive patient outcomes in the education of diabetic hemodialysis patients. It is necessary for hemodialysis nurses to educate diabetic patients on foot care knowledge, improve foot care behaviors, and prevent the development of foot ulcers and lower extremity amputations. However, the lack of studies in the literature on nurse-led foot care education interventions based on the health belief model for diabetic patients undergoing hemodialysis constitutes the strength and unique aspect of this study. The research will be conducted using a randomized controlled pretest-posttest design.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion criteria: * Voluntary participation in the study * Literacy * Absence of psychiatric distress * Being over 18 years of age * Open to communication and cooperation, no speech problems * Receiving continuous hemodialysis treatment * Having been diagnosed with diabetes for at least 6 months Exclusion criteria: * Unwillingness to participate in the study or desire to withdraw from the study * Receiving acute hemodialysis treatment * Being under 18 years of age * Open to communication and cooperation, no speech problems

Primary outcome measure(s)

  • Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on the foot care knowledge levels of diabetic hemodialysis patients. — 6 weeks
    The Diabetic Foot Knowledge Scale will be used to measure the foot care knowledge levels of the patients.
  • Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on foot care behaviors. — 6 weeks
    The Foot Care Behavior Scale will be used to measure foot care behaviors.
  • Evaluation of the effect of diabetic foot care training, prepared according to the Health Belief Model, on self-efficacy. — 6 weeks
    The Diabetic Foot Care Self-Efficacy Scale will be used to evaluate self-efficacy.

Trial sites (3)

FacilityCityRegionStatus
Fethi Sekin Şehir Hastanesi Elâzığ Merkez Recruiting
Fırat Üniversitesi Hastanesi Elâzığ Merkez Recruiting
Özel Elazığ Diyaliz Merkezi Elâzığ Merkez Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07462741 on ClinicalTrials.gov ↗ ← All trials in Turkey